Anthropologist Zhiying Ma explores mental health care in China, including tensions between Western psychiatry and socially-oriented local frameworks.
MIA’s Peter Simons interviews Laysha Ostrow about her mental health research and consulting company, the inclusion of peer specialists in mental health care, and her personal experience with the mental health system.
In an interview with MIA's Akansha Vaswani, narrative therapist Jennifer Freeman calls for a shift away from individualistic approaches to 'eco-anxiety' and toward responses that connect us all to a counter-tsunami of action for the planet.
An interview with Celia Brown: psychiatric survivor, human rights activist, and president of MindFreedom International.
An interview with Peter Mayfield, founder and Executive Director of the Gateway Mountain Center. Peter talks of his journey from mountaineering to his role as an educator and mentor, and how enabling children and adolescents to connect with nature has such a profound effect on their health and wellbeing.
School Psychologist Scott Greenspan discusses how to promote exercise and mental wellbeing for adolescents stuck indoors during the pandemic.
Tony Kendrick, a professor of Primary Care at the University of Southampton, has found through his research and practice that too many people are being prescribed antidepressants long-term without the information and support necessary to get off of them.
Dr. Anthony Ryan Hatch is a sociologist and associate professor of Science in Society, African American studies and Environmental Studies at Wesleyan University, who...
Dr. Vance Trudeau discusses his study's finding that antidepressants may have far-reaching, adverse effects that last up to three generations.
MIA's Gavin Crowell-Williamson interviews PharmedOut founder Dr. Adriane Fugh-Berman about Big Pharma's influence on medical education.
Dr. Gail Hornstein, author of Agnes’s Jacket: A Psychologist’s Search for the Meanings of Madness, discusses the importance of personal narratives and service-user activism in the context of the global mental health movement.
Researchers, Jon Jureidini, Jay Amsterdam and Leemon McHenry, have taken a closer look at the data from a randomized control trial of citalopram (Celexa) that was ghostwritten and then used by the manufacturers to support claims of the drug’s efficacy and safety in the treatment of child and adolescent depression. To get the background on this story, we connected with Dr. Leemon McHenry, an investigator in this study and a lecturer in philosophy at California State University, Northridge.
MIA’s Tim Beck interviews Dr. Felicity Thomas and Dr. Richard Byng about their report, Poverty, Pathology, and Pills, which situates increasing rates of mental health diagnosis and psychiatric prescriptions within socioeconomic and policy trends across the UK.
12Page 2 of 2